Eikon Therapeutics
$5.68
0
+$0.37+6.97% 21:00 Today
+$0.00+0%21:00After hours
Statistics
Day High
5.76
Day Low
5.21
52W High
17.4
52W Low
5.01
Volume
409,342
Avg. Volume
561,631
Mkt Cap
307.51M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Dec 2Expected
Q1 2026
Q2 2026
Next
-2.46
-2.17
-1.88
-1.58
Expected EPS
-1.69759
Actual EPS
N/A
Financials
9.94%Profit Margin
Profitable118.12MRevenue
11.74MNet Income
Analyst Ratings
$13.50Average Price Target
The highest estimate is 23.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 50%
Hold 0%
Sell 50%
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.
Show More
CEO
Roger Perlmutter
Employees
384
Country
United States
ISIN
US2825641036
Listings
0 Comments
Share your thoughts
FAQs
What is Eikon Therapeutics stock price today?▼
The current price of EIKN is $5.68 USD — it has increased by +6.97% in the past 24 hours. Watch Eikon Therapeutics stock price performance more closely on the chart.
What is Eikon Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Eikon Therapeutics stocks are traded under the ticker EIKN.
What is Eikon Therapeutics market cap?▼
Today Eikon Therapeutics has the market capitalization of 307.51M
When is the next Eikon Therapeutics earnings date?▼
Eikon Therapeutics is going to release the next earnings report on December 2, 2026.
What were Eikon Therapeutics earnings last quarter?▼
EIKN earnings for the last quarter are -1.63 USD per share, whereas the estimation was -1.58 USD resulting in a -2.84% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Eikon Therapeutics revenue for the last year?▼
Eikon Therapeutics revenue for the last year amounts to 118.12M USD.
What is Eikon Therapeutics net income for the last year?▼
EIKN net income for the last year is 11.74M USD.
How many employees does Eikon Therapeutics have?▼
As of November 2, 2026, the company has 384 employees.
In which sector is Eikon Therapeutics located?▼
Eikon Therapeutics operates in the Health & Wellness sector.
When did Eikon Therapeutics complete a stock split?▼
Eikon Therapeutics has not had any recent stock splits.
Where is Eikon Therapeutics headquartered?▼
Eikon Therapeutics is headquartered in MILLBRAE, United States.